We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 6.16%
3 Industrials 5.09%
4 Consumer Discretionary 4.89%
5 Healthcare 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYD icon
5851
CALL
China Yuchai International
CYD
$1.7B
$396K ﹤0.01%
+16,500
New +$394K
GLPI icon
5852
CALL
Gaming and Leisure Properties
GLPI
$12.7B
$396K ﹤0.01%
10,700
-6,200
-37% -$226K
PEGA icon
5853
PUT
Pegasystems
PEGA
$5.31B
$396K ﹤0.01%
16,800
-6,200
-27% -$166K
UGL icon
5854
ProShares Ultra Gold
UGL
$801M
$396K ﹤0.01%
38,984
-52,112
-57% -$511K
WHG icon
5855
Westwood Holdings Group
WHG
$186M
$396K ﹤0.01%
+5,986
New +$397K
ACHC icon
5856
PUT
Acadia Healthcare
ACHC
$2.87B
$395K ﹤0.01%
+12,100
New +$419K
BF.B icon
5857
Brown-Forman Class B
BF.B
$13B
$395K ﹤0.01%
8,991
-777,997
-99% -$29.7M
ERII icon
5858
Energy Recovery
ERII
$426M
$395K ﹤0.01%
45,184
+7,407
+20% +$67.5K
EWBC icon
5859
CALL
East-West Bancorp
EWBC
$18.7B
$395K ﹤0.01%
6,500
-1,600
-20% -$95.4K
IQLT icon
5860
iShares MSCI Intl Quality Factor ETF
IQLT
$14.3B
$395K ﹤0.01%
+13,306
New +$390K
NICE icon
5861
PUT
Nice
NICE
$5.99B
$395K ﹤0.01%
4,300
+800
+23% +$68.1K
NTLA icon
5862
Intellia Therapeutics
NTLA
$1.67B
$395K ﹤0.01%
20,540
+6,530
+47% +$151K
STWD icon
5863
PUT
Starwood Property Trust
STWD
$6.03B
$395K ﹤0.01%
18,500
-3,400
-16% -$73.7K
LUMO
5864
PUT
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$395K ﹤0.01%
5,411
+767
+17% +$63.4K
NOV icon
5865
NOV
NOV
$7.54B
$394K ﹤0.01%
+10,951
New +$370K
SFL icon
5866
CALL
SFL Corp
SFL
$1.64B
$394K ﹤0.01%
25,400
-36,700
-59% -$551K
NPKI
5867
NPK International
NPKI
$1.21B
$394K ﹤0.01%
+45,806
New +$415K
LTS
5868
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$394K ﹤0.01%
124,531
+59,067
+90% +$183K
CALL
5869
PUT
DELISTED
magicJack VocalTec Ltd
CALL
$393K ﹤0.01%
+46,500
New +$352K
SRS icon
5870
ProShares UltraShort Real Estate
SRS
$15.6M
$392K ﹤0.01%
+1,678
New +$399K
YINN icon
5871
Direxion Daily FTSE China Bull 3X ETF
YINN
$653M
$391K ﹤0.01%
575
+5
+0.9% +$3.32K
RRD
5872
CALL
DELISTED
RR Donnelley & Sons Co.
RRD
$391K ﹤0.01%
42,000
+6,100
+17% +$55.7K
CMD
5873
PUT
DELISTED
Cantel Medical Corporation
CMD
$391K ﹤0.01%
3,800
-2,600
-41% -$259K
AGU
5874
CALL
DELISTED
Agrium
AGU
$391K ﹤0.01%
3,400
-2,100
-38% -$228K
CRAI icon
5875
CRA International
CRAI
$1.06B
$390K ﹤0.01%
8,676
-174
-2% -$7.63K

Similar funds

Ken Griffin's Q4 2017 Portfolio in Review

As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.